Summary
- Current Price
- As of today, ARWR price is $72.05, down -3.03% in the most recent trading session on
- Current Price All-Time High
- ARWR price is currently -97.54% below its historical high of $2,925.00 set on
- Market Cap
- ARWR current market cap is $10B, up +338.34% over the past 365 days
- Revenue
- ARWR current annual revenue is $829.45M, up +23258.15% year-over-year
- Next Earnings
- The next earnings release for ARWR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Arrowhead Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ARWR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arrowheadpharma.com |
| Employees | 609 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $72.05 | |
| Price, 1D Change | -3.03% | |
| Market Cap | $10B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.52 | |
| Revenue | $829M | |
| Revenue, 1Y Change | +23,258.15% | |
| EPS | -$0.01 | |
| EPS, 1Y Change | +99.76% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.01 | |
| EPS Estimate | N/A | -$3.08 |
| EPS Est. Change | N/A | -25,179.51% |
| Revenue | $829.45M | |
| Revenue Estimate | N/A | $442.33M |
| Revenue Est. Change | N/A | -46.67% |
| Current Price | $72.05 | |
| Price Target | - | $97.00 |
| Price Tgt. Change | - | +34.63% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.53 | -$5.00 | -10.53% | |
| -$0.03 | -$0.01 | +63.69% | |
| -$3.08 | N/A | -25,179.51% | |
| -$4.57 | N/A | -37,318.85% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $61.60M | $3.55M | -94.24% | |
| $757.44M | $829.45M | +9.51% | |
| $442.33M | N/A | -46.67% | |
| $324.49M | N/A | -60.88% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +329.89% | |
| Price, 3Y | +106.92% | |
| Market Cap, 1Y | +338.34% | |
| Market Cap, 3Y | +172.14% | |
| Revenue, 1Y | +23,258.15% | |
| Revenue, 3Y | +241.01% | |
| EPS, 1Y | +99.76% | |
| EPS, 3Y | +99.27% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $72.05 | |
| SMA 200 | $62.80 | |
| SMA 50 | $77.40 | |
| EMA 200 | $62.22 | |
| EMA 50 | $76.26 | |
| MACD | -$0.94 | |
| Beta | 1.52 | |
| ATR | $4.06 | |
| 14-Day RSI | 43.31 | |
| 10-Day Volatility | 57.77% | |
| 1-Year Volatility | 64.66% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $829.45M | |
| EPS | -$0.01 | |
| Gross Profit | $805.52M | |
| Gross Margin | 97.12% | |
| Operating Income | $98.35M | |
| Operating Margin | 11.86% | |
| Net Income | $30.11M | |
| Net Margin | 3.63% | |
| EBITDA | $122.27M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.57 | |
| 4.86 | ||
| 4.86 | ||
| - | ||
| 2 | ||
| 6.28 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| 16.32 | ||
| 16.53 | ||
| -49.55 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $466.05M | |
| $919.37M | ||
| $1.45B | ||
| $950.64M | ||
| $947.02M | ||
| $195.49M | ||
| Total Debt | $733.68M | |
| $47.29M | ||
| $17.67M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $831.08M | ||
| $707.17M | ||
| $23.93M | ||
| $0.00 | ||
| $23.93M | ||
| $0.00 | ||
| $21.42M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $179.55M | ||
| -$129.29M | ||
| $74.01M | ||
| Capex | $22.67M | |
| $156.89M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| Stifel | ||
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Leerink Partners | → | |
| Bernstein | → | |
| RBC Capital | → | |
| JP Morgan | ||
| Morgan Stanley | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ARWR
FAQ
What is the ticker symbol for Arrowhead Pharmaceuticals, Inc.?
The ticker symbol for Arrowhead Pharmaceuticals, Inc. is NASDAQ:ARWR
Does Arrowhead Pharmaceuticals, Inc. pay dividends?
No, Arrowhead Pharmaceuticals, Inc. does not pay dividends
What sector is Arrowhead Pharmaceuticals, Inc. in?
Arrowhead Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Arrowhead Pharmaceuticals, Inc. in?
Arrowhead Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Arrowhead Pharmaceuticals, Inc. based in?
Arrowhead Pharmaceuticals, Inc. is headquartered in United States
When did Arrowhead Pharmaceuticals, Inc. go public?
Arrowhead Pharmaceuticals, Inc. initial public offering (IPO) was on December 16, 1993
Is Arrowhead Pharmaceuticals, Inc. in the S&P 500?
No, Arrowhead Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Arrowhead Pharmaceuticals, Inc. in the NASDAQ 100?
No, Arrowhead Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Arrowhead Pharmaceuticals, Inc. in the Dow Jones?
No, Arrowhead Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Arrowhead Pharmaceuticals, Inc. last earnings report?
Arrowhead Pharmaceuticals, Inc.'s most recent earnings report was on May 7, 2026
When does Arrowhead Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Arrowhead Pharmaceuticals, Inc. is August 6, 2026
Data Sources & References
- ARWR Official Website arrowheadpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
- ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
- ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr